RESUMEN
This study was carried out in order to compare the relative bioavailability of two different formulations containing 400 mg of acetaminophen + 4 mg of phenylephrine hydrochloride + 4 mg of chlorpheniramine maleate, Test formulation (Cimegripe®) and Reference formulation (Resfenol®) in 84 healthy volunteers of both sexes under fasting conditions. The study was conducted in a single dose, randomized, open-label, crossover 3-way and partially replicated. The tolerability was evaluated by the monitoring of adverse events and vital signs, results of clinical and laboratory tests. Plasma concentrations were quantified by validated bioanalytical methods using the ultra-performance liquid chromatography coupled to tandem mass spectrometry. The Cmax, Tmax, AUC0-t, AUC0-inf, T1/2 and Kel pharmacokinetic parameters were calculated from these obtained concentrations. The 90% confidence intervals were constructed for the ratio reference/test from the geometric average of the Cmax and AUC parameters which were comprised between 80% and 125%. Only the Cmax parameter of the phenylephrine was applied the scaled average bioequivalence due to the intraindividual coefficient of variation > 30% obtained, thus extending the acceptance limits of the interval. It can be concluded that the two formulations were bioequivalent in terms of rate and absorption extent and thus interchangeable
Asunto(s)
Humanos , Masculino , Femenino , Fenilefrina/análisis , Cápsulas/clasificación , Disponibilidad Biológica , Clorfeniramina/análisis , Acetaminofén/análisis , Espectrometría de Masas/métodos , Dosis Única , Ayuno/efectos adversos , Estudios Cruzados , Absorción/efectos de los fármacos , Espectrometría de Masas en Tándem/métodos , Voluntarios Sanos/clasificaciónRESUMEN
The efficacy of gliquidone for the treatment of diabetic nephropathy was investigated by implanting micro-osmotic pumps containing gliquidone into the abdominal cavities of Goto-Kakizaki (GK) rats with diabetic nephropathy. Blood glucose, 24âh urinary protein, and 24âh urinary albumin levels were measured weekly. After 4 weeks of gliquidone therapy, pathological changes in the glomerular basement membrane (GBM) were examined using an electron microscope. Real-time PCR, western blotting, and immunohistochemistry were employed to detect glomerular expression of receptors for advanced glycation end products (RAGE) (AGER), protein kinase C ß (PKCß), and protein kinase A (PKA) as well as tubular expression of the albumin reabsorption-associated proteins: megalin and cubilin. Human proximal tubular epithelial cells (HK-2 cells) were used to analyze the effects of gliquidone and advanced glycation end products (AGEs) on the expression of megalin and cubilin and on the absorption of albumin. Gliquidone lowered blood glucose, 24âh urinary protein, and 24âh urinary albumin levels in GK rats with diabetic nephropathy. The level of plasma C-peptide increased markedly and GBM and podocyte lesions improved dramatically after gliquidone treatment. Glomerular expression of RAGE and PKCß decreased after gliquidone treatment, while PKA expression increased. AGEs markedly suppressed the expression of megalin and cubulin and the absorption of albumin in HK-2 cells in vitro, whereas the expression of megalin and cubilin and the absorption of albumin were all increased in these cells after gliquidone treatment. In conclusion, gliquidone treatment effectively reduced urinary protein in GK rats with diabetic nephropathy by improving glomerular lesions and promoting tubular reabsorption.
Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Túbulos Renales/efectos de los fármacos , Proteinuria/metabolismo , Proteinuria/prevención & control , Compuestos de Sulfonilurea/farmacología , Absorción/efectos de los fármacos , Animales , Células Cultivadas , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/orina , Nefropatías Diabéticas/tratamiento farmacológico , Nefropatías Diabéticas/orina , Evaluación Preclínica de Medicamentos , Humanos , Túbulos Renales/metabolismo , Masculino , Ratas , Ratas EndogámicasRESUMEN
Iodine deficiency is a common phenomenon, threatening the whole global human population. Recommended daily intake of iodine is 150 µg for adults and 250 µg for pregnant and breastfeeding women. About 50% of human population can be at risk of moderate iodine deficiency. Due to this fact, increased iodine supplementation is recommended, through intake of iodized mineral water and salt iodization. The aim of this study was to investigate permeation and absorption of iodide from iodine bioplex (experimental group) in comparison with potassium iodide (controls). Permeation and absorption processes were investigated in vitro using a porcine intestine. The experimental model was based on a standard Franz diffusion cell (FD-Cell). The iodine bioplex was produced using Saccharomyces cerevisiae yeast and whey powder: iodine content - 388 µg/g, total protein - 28.5%, total fat - 0.9%., glutamic acid - 41.2%, asparaginic acid - 29.4%, lysine - 24.8%; purchased from: F.Z.N.P. Biochefa, Sosnowiec, Poland. Potassium iodide was used as controls, at 388 µg iodine concentration, which was the same as in iodine-enriched yeast bioplex. A statistically significant increase in iodide permeation was observed for iodine-enriched yeast bioplex in comparison with controls - potassium iodide. After 5h the total amount of permeated iodide from iodine-enriched yeast bioplex was 85%, which is ~ 2-fold higher than controls - 37%. Iodide absorption was by contrast statistically significantly higher in controls - 7.3%, in comparison with 4.5% in experimental group with iodine-enriched yeast bioplex. Presented results show that iodide permeation process dominates over absorption in case of iodine-enriched yeast bioplex.
Asunto(s)
Yoduros/farmacología , Polímeros/farmacología , Yoduro de Potasio/farmacología , Absorción/efectos de los fármacos , Adulto , Animales , Permeabilidad de la Membrana Celular/efectos de los fármacos , Suplementos Dietéticos , Femenino , Humanos , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Yoduros/química , Polímeros/química , Embarazo , Saccharomyces cerevisiae/química , PorcinosRESUMEN
OBJECTIVE: To study in vivo mercury absorption and accumulation through repeated transdermal administration of Yuhong ointment containing calomel, in order to provide scientific evidences for clinical safe medication. METHOD: A total of 100 SD rats were randomly classified into five groups: the control group, the Yuhong ointment group, the double-concentration Yuhong Ointment group, the quadruple-concentration Yuhong ointment group and the 1.6% calomel group. The rats were treated with the dosage of 0.04 g . cm-2 by repeated transdermal administration for 2, 4 weeks. After the drug discontinuance for 4 weeks, the levels of mercury in blood, urine, and tissues of heart, liver, brain and kidney were determined, respectively. RESULT: Compared with the control group, the blood mercury level of the Yuhong ointment group show no obvious change after treatment for 4 weeks. However, the levels of mercury in blood and urine of other experimental groups increased significantly with time and the increase in dosage, and so did the level of mercury in major organ. At 4 weeks, all experimental groups showed increase in the content of mercury, and kidneys displayed the highest level, whereas brain displayed the lowest level After the drug discontinuance for 4 weeks, the mercury level in blood and urine of every dose group recovered to normal, with significant decline in the content of mercury in each organ. CONCLUSION: After transdermal administration in rats for 4 weeks, there was no obvious absorption of mercury in blood. Mercury was mainly accumulated in kidneys and excreted through urine. The results suggest that the patients' mercury content and kidney function indexes need to be monitored in long-term clinical use of Yuhong ointment.
Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/efectos adversos , Mercurio/farmacocinética , Absorción/efectos de los fármacos , Animales , Femenino , Masculino , Mercurio/análisis , Mercurio/sangre , Mercurio/orina , Pomadas , Ratas , Ratas Sprague-Dawley , Seguridad , Factores de TiempoRESUMEN
OBJECTIVE: To investigate the effect of Chinese herbal medicine with Supplement Qi and Activating Blood Circulation (huangqi and danshen) on urinary protein, kidney function and tubular reabsorption of diabetic nephropathy rats. METHODS: SD rats were randomly divided into a nondiabetic control group (normal group) and three groups in which diabetes were induced by a single intraperitoneal injection of freshly prepared streptozotocin( STZ,55 mg/kg body weight). Then the diabetes rats were randomly assigned to three groups: diabetic model group, Supplement Qi and Activating Blood Circulation traditional Chinese medicine group (huangqi and danshen group) and Gliquidone group (as a reference hypoglycemic drug). Each group was treated with corresponding drugs for 6 weeks. At the end of the study, the rats from each group were injected with FITC-labeled BSA through tail vein. The 24 h urinary protein excretion were measured and blood was collected for measuring plasma glucose levels, serum creatinine (Cr), blood urea nitrogen (BUN), triglyceride (TG) and total cholesterol (T-CHO). Renal tissue was used to measure the level of LPO,SOD,GSH-Px and AGEs and Paraffin-embedded sections were stained with HE, PAS and immunohistochemistry. RESULTS: The plasma glucose, the 24 h urinary protein excretion, the levels of serum Cr, BUN, TG and T-CHO in STZ-induced diabetic rats were higher than those of nondiabetic rats. Diabetic rats showed significantly increase in LPO and AGEs (P < 0.01) and decrease in antioxidant enzyme activity (both GSH-Px and SOD) (P < 0.05) as compared with non-diabetic control rats. Treatment with the Supplement Qi and Activating Blood Circulation traditional Chinese medicine for 6 weeks in diabetic rats significantly reduced the 24 h urinary protein excretion compared with model control (P < 0.01), and markedly decreased the levels of serum Cr,BUN,TG and T-CHO as compared with those of diabetic rat (P < 0.05). The levels of LPO and AGEs were decreased and the activity of GSH-Px was increased by Supplement Qi and Activating Blood Circulation treatment. The kidney proximal tubule lesions were improved and the reabsorption of FITC-BSA in tubular was increased in diabetic rats treated by huangqi and danshen, and the expression of megalin in proximal tubular was enhanced as compared with diabetic rats. CONCLUSION: Diabetic nephropathy rats treated with traditional Chinese medicine therapeutic principles "Supplement Qi and Activating Blood Circulation" can reduce the 24 h urinary protein excretion and improve the function of tubular reabsorption. These protect effects may be in correlation with enhancement the renal tissue activity of antioxidant and up-regulation the expression of megalin in renal tubular epithelial cells in diabetic rats.
Asunto(s)
Nefropatías Diabéticas/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Túbulos Renales/efectos de los fármacos , Proteína 2 Relacionada con Receptor de Lipoproteína de Baja Densidad/metabolismo , Absorción/efectos de los fármacos , Animales , Astragalus propinquus/química , Biomarcadores/sangre , Biomarcadores/orina , Glucemia/metabolismo , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/tratamiento farmacológico , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/fisiopatología , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/administración & dosificación , Pruebas de Función Renal , Túbulos Renales/metabolismo , Túbulos Renales/fisiopatología , Masculino , Fitoterapia/métodos , Ratas , Ratas Sprague-Dawley , Salvia miltiorrhiza/química , EstreptozocinaRESUMEN
Vitamin D is known to increase Ca absorption in adults. However, the threshold vitamin D status to benefit Ca absorption is lower than the target vitamin D status for higher bone mineral density and lower fracture risk, pointing to another pathway for vitamin D to benefit bone. One possibility is by affecting osteoblast and osteoclasts directly. Vitamin D-related bone metabolism may also be affected by soy isoflavones, which selectively bind to the estrogen receptor β and may reduce bone loss in postmenopausal women. We discuss a possible synergistic effect of soy isoflavones and vitamin D on bone by affecting osteoblast and osteoclast formation and activity in postmenopausal women.
Asunto(s)
Glycine max/química , Isoflavonas/administración & dosificación , Posmenopausia , Vitamina D/administración & dosificación , Absorción/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Calcio/metabolismo , Sinergismo Farmacológico , Femenino , Genisteína/administración & dosificación , Fracturas de Cadera , Humanos , Persona de Mediana Edad , Osteoporosis Posmenopáusica/prevención & control , Fitoestrógenos/administración & dosificación , Factores de RiesgoRESUMEN
Iron homeostasis is controlled by hepcidin (Hpc) as well as other ways. Hpc expression is regulated by iron (Fe) storage and by inflammation, but the joint effect of both stimuli remains unclear. We studied the modulatory role of inflammatory agents (IL6 and LPS) over Hpc and DMT1 mRNA expression in HepG2 cells preloaded with Fe. HepG2 cells were preloaded with different Fe concentrations (holo-Tf or Fe-NTA) and then incubated with IL6 or LPS. We measured intracellular Fe levels by AAS with graphite furnace, transferrin receptor (TfR) by ELISA and mRNA relative abundance of Hpc and DMT1 by qRT-PCR. The maximum effect on Fe uptake was observed in cells incubated with 30 ng/ml IL6 (p < 0.01) and 500 ng/ml LPS (p < 0.05). In HepG2 cells preloaded with holo-Tf or Fe-NTA and challenged with IL6 and LPS, we observed a decreased: (a) Hpc mRNA relative abundance (two-way ANOVA: p < 0.05 and p < 0.001, respectively), (b) DMT1 mRNA relative abundance and TfR1 protein levels (two-way ANOVA: p < 0.001), and (c) intracellular Fe concentration (two-way ANOVA: p < 0.001 and p < 0.01, respectively) compared to control cells incubated only with Fe (holo-Tf or Fe-NTA). Our results support the idea that Fe storage and inflammation act together to regulate Fe homeostasis and suggest a negative regulation in this hepatic cellular model to prevent excessive increases in Hpc.
Asunto(s)
Péptidos Catiónicos Antimicrobianos/metabolismo , Regulación de la Expresión Génica , Hepatocitos/metabolismo , Interleucina-6/metabolismo , Hierro/metabolismo , Lipopolisacáridos/farmacología , Absorción/efectos de los fármacos , Péptidos Catiónicos Antimicrobianos/genética , Transporte Biológico/efectos de los fármacos , Proteínas de Transporte de Catión/genética , Proteínas de Transporte de Catión/metabolismo , Cloruros/efectos adversos , Cloruros/metabolismo , Suplementos Dietéticos/efectos adversos , Compuestos Férricos/efectos adversos , Compuestos Férricos/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Células Hep G2 , Hepatocitos/efectos de los fármacos , Hepatocitos/inmunología , Hepcidinas , Humanos , Hierro/envenenamiento , Sobrecarga de Hierro/inducido químicamente , Sobrecarga de Hierro/inmunología , Sobrecarga de Hierro/metabolismo , Radioisótopos de Hierro , Lipopolisacáridos/toxicidad , Ácido Nitrilotriacético/efectos adversos , Ácido Nitrilotriacético/análogos & derivados , Ácido Nitrilotriacético/metabolismo , Concentración Osmolar , ARN Mensajero/metabolismo , Receptores de Transferrina/genética , Receptores de Transferrina/metabolismo , Espectrofotometría AtómicaRESUMEN
OBJECTIVE: To investigate action of hydrophilic constituents from Coptidis Rhizoma on glucose-lowering effect metabolism of berberine in HepG2 cells. METHOD: Hydrophilic fractions of Coptidis Rhizoma were prepared by high speed counter current chromatography and separated by silica gel column chromatography. MTT assay was used to monitor the proliferation of HepG2 cells, and Kit was used to test the glucose consumption in culture solution. RESULT: Choline was separated from Coptidis Rhizoma for the first time. Cell assay showed choline can significantly increase the glucose lowering effect of berberine and improve the cytotoxicity of berberine within test concentration. Compared with same dose of berberine, berberine 38 mg x L(-1) in combination with choline 100 mg x L(-1) can make glucose consumption increase by 34% and elevate cell livability up to 75% in HepG2 cells. CONCLUSION: The results suggest that choline had a synergistic effect on improving glucose absorption of berberine and decreasing cytotoxicity of berberine.
Asunto(s)
Berberina/farmacología , Colina/aislamiento & purificación , Colina/farmacología , Medicamentos Herbarios Chinos/química , Glucosa/metabolismo , Absorción/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Colina/análisis , Colina/química , Cromatografía Líquida de Alta Presión , Coptis chinensis , Sinergismo Farmacológico , Células Hep G2 , Humanos , Interacciones Hidrofóbicas e HidrofílicasRESUMEN
OBJECTIVE: To study the impact of saikosaponin on absorption and transport of paeoniflorin in Caco-2 cell model. METHOD: The concentration of paeoniflorin in cell culture medium was measured by UPLC and the apparent permeability coefficients (P(app)) was calculated to study differences in bi-direction transport of paeoniflorin solutions of different concentrations and its compatibility with saikosaponin a, and saikosaponin d in Caco-2 cell model. Meanwhile, the electric resistance of Caco-2 cell was determined before and after the experiment. RESULT: The amount of paeoniflorin increased linearly with the transport of Caco-2 cell monolayer in 4 h, with a lower absorptive permeability, which was (0.98 +/- 0.10) x 10(-6), (0.92 +/- 0.09) x 10(-6), (0.89 +/- 0.04) x 10(-6) cm x s(-1) at the concentration of 20, 50, 100 micromol x L(-1), respectively. After compatibility with saikosaponin a and saikosaponin d, the absorptive permeability of paeoniflorin increased by 2.37 times and 2.54 times, respectively, while the electric resistance of Caco-2 cell was decreased significantly after the experiment. CONCLUSION: Saikosaponin a, d can enhance the absorption of paeoniflorin in Caco-2 cell monolayer, which may be related to saikosaponin's ability to open up intercellular tight junctions among Caco-2 cells.
Asunto(s)
Benzoatos/metabolismo , Hidrocarburos Aromáticos con Puentes/metabolismo , Glucósidos/metabolismo , Ácido Oleanólico/análogos & derivados , Saponinas/farmacología , Absorción/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Células CACO-2 , Relación Dosis-Respuesta a Droga , Fenómenos Electrofisiológicos/efectos de los fármacos , Humanos , Monoterpenos , Ácido Oleanólico/farmacologíaRESUMEN
OBJECTIVE: To detect absorbed bioactive compounds of the water extract whose pharmacodynamic effect was craniocerebral protection for quality control assessment. METHODS: Anthraquinones in water extract of rhubarb (WER), in cerebrospinal fluid (CSF) of patients with traumatic brain injury (TBI) and in ipsilateral cortex of TBI rats following oral WER were respectively explored by ultra performance liquid chromatography with photodiode array detector (UPLC-PDA) method developed in the present study. The effects of anthraquinones absorbed into injured cortex on superoxidase dismutase (SOD) activity in TBI rats were detected. The antioxidative anthraquinones absorbed into target organ were evaluated for quality control of WER. RESULTS: Anthraquinones in WER were aloe-emodin, rhein, emodin, chrysophanol, and physcion. Only the last anthraquinone was found in CSF and in ipsilateral cortex under this chromatographic condition. Physcion increased SOD activity in TBI rats significantly. CONCLUSIONS: Physcion was the main active compound of rhubarb against craniocerebral injury via antioxidant pathway. According to our strategy, the exploration of physcion suggested the possibility of a novel quality control of WER in treating TBI injury.
Asunto(s)
Productos Biológicos/análisis , Cromatografía Liquida/instrumentación , Cromatografía Liquida/métodos , Extractos Vegetales/química , Control de Calidad , Rheum/química , Agua/química , Absorción/efectos de los fármacos , Animales , Antraquinonas/líquido cefalorraquídeo , Antraquinonas/química , Productos Biológicos/líquido cefalorraquídeo , Productos Biológicos/química , Lesiones Encefálicas/tratamiento farmacológico , Lesiones Encefálicas/patología , Emodina/administración & dosificación , Emodina/análogos & derivados , Emodina/farmacología , Emodina/uso terapéutico , Humanos , Límite de Detección , Modelos Lineales , Masculino , Ratas , Ratas Sprague-Dawley , Estándares de Referencia , Reproducibilidad de los ResultadosRESUMEN
The Kv1.3 channel is a recognized target for pharmaceutical development to treat autoimmune diseases and organ rejection. ShK-186, a specific peptide inhibitor of Kv1.3, has shown promise in animal models of multiple sclerosis and rheumatoid arthritis. Here, we describe the pharmacokinetic-pharmacodynamic relationship for ShK-186 in rats and monkeys. The pharmacokinetic profile of ShK-186 was evaluated with a validated high-performance liquid chromatography-tandem mass spectrometry method to measure the peptide's concentration in plasma. These results were compared with single-photon emission computed tomography/computed tomography data collected with an ¹¹¹In-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugate of ShK-186 to assess whole-blood pharmacokinetic parameters as well as the peptide's absorption, distribution, and excretion. Analysis of these data support a model wherein ShK-186 is absorbed slowly from the injection site, resulting in blood concentrations above the Kv1.3 channel-blocking IC50 value for up to 7 days in monkeys. Pharmacodynamic studies on human peripheral blood mononuclear cells showed that brief exposure to ShK-186 resulted in sustained suppression of cytokine responses and may contribute to prolonged drug effects. In delayed-type hypersensitivity, chronic relapsing-remitting experimental autoimmune encephalomyelitis, and pristane-induced arthritis rat models, a single dose of ShK-186 every 2 to 5 days was as effective as daily administration. ShK-186's slow distribution from the injection site and its long residence time on the Kv1.3 channel contribute to the prolonged therapeutic effect of ShK-186 in animal models of autoimmune disease.
Asunto(s)
Enfermedades Autoinmunes/tratamiento farmacológico , Canal de Potasio Kv1.3/antagonistas & inhibidores , Proteínas/farmacología , Linfocitos T/efectos de los fármacos , Absorción/efectos de los fármacos , Absorción/inmunología , Animales , Artritis/tratamiento farmacológico , Artritis/inmunología , Artritis/metabolismo , Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/metabolismo , Citocinas/inmunología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Encefalomielitis Autoinmune Experimental/tratamiento farmacológico , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/metabolismo , Femenino , Humanos , Concentración 50 Inhibidora , Canal de Potasio Kv1.3/inmunología , Canal de Potasio Kv1.3/metabolismo , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Macaca fascicularis , Bloqueadores de los Canales de Potasio/inmunología , Bloqueadores de los Canales de Potasio/farmacocinética , Bloqueadores de los Canales de Potasio/farmacología , Proteínas/farmacocinética , Ratas , Ratas Sprague-Dawley , Saimiri , Linfocitos T/inmunología , Linfocitos T/metabolismo , Distribución Tisular/efectos de los fármacos , Distribución Tisular/inmunologíaRESUMEN
Δ9-Tetrahydrocannabinol (THC) produces transient psychomimetic effects in healthy volunteers, constituting a pharmacological model for psychosis. The dopaminergic antagonist haloperidol has previously been shown to reduce these effects. This placebo-controlled, cross-over study in 49 healthy, male, mild cannabis users aimed to further explore this model by examining the effect of a single oral dose of olanzapine (with dopaminergic, serotonergic, adrenergic, muscarinergic and histaminergic properties) or two oral doses of diphenhydramine (histamine antagonist) on the effects of intrapulmonarily administered THC. Transient psychomimetic symptoms were seen after THC administration, as measured on the positive and negative syndrome scale (20.6% increase on positive subscale, p<0.001) and the visual analogue scale for psychedelic effects (increase of 10.7 mm on feeling high). Following the combination of THC and olanzapine, the positive subscale increased by only 13.7% and feeling high by only 8.7 mm. This reduction of THC effects on the positive subscale failed to reach statistical significance (p=0.066). However, one-third of the subjects did not show an increase in psychomimetic symptoms after THC alone. Within responders, olanzapine reduced the effects of THC on the positive subscale (p=0.005). Other outcome measures included pharmacokinetics, eye movements, postural stability, pupil/iris ratio, and serum concentrations of cortisol and prolactin.
Asunto(s)
Antipsicóticos/uso terapéutico , Benzodiazepinas/uso terapéutico , Dronabinol/antagonistas & inhibidores , Alucinógenos/antagonistas & inhibidores , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Trastornos Psicóticos/tratamiento farmacológico , Absorción/efectos de los fármacos , Adolescente , Adulto , Antipsicóticos/sangre , Antipsicóticos/farmacocinética , Benzodiazepinas/sangre , Benzodiazepinas/farmacocinética , Estudios Cruzados , Método Doble Ciego , Dronabinol/sangre , Dronabinol/farmacocinética , Dronabinol/toxicidad , Interacciones Farmacológicas , Consumidores de Drogas , Alucinógenos/sangre , Alucinógenos/farmacocinética , Alucinógenos/toxicidad , Antagonistas de los Receptores Histamínicos H1/sangre , Antagonistas de los Receptores Histamínicos H1/farmacocinética , Humanos , Masculino , Tasa de Depuración Metabólica/efectos de los fármacos , Persona de Mediana Edad , Países Bajos , Síndromes de Neurotoxicidad/sangre , Síndromes de Neurotoxicidad/prevención & control , Olanzapina , Trastornos Psicóticos/sangre , Adulto JovenRESUMEN
The objective of the present study was to evaluate the effect of the bread supplemented with whole amaranth flour (0, 20 and 40%) on iron bioavailability using Caco-2 cells model. The phytate and lower myo-inositol phosphates content in in vitro bread digests were measured by high pressure liquid chromatography. The breads made with amaranth showed significant increase of soluble phytates levels (up to 1.20 µmol/g in dry matter for the 40% of substitution) in comparison with controls, which have not detectable values. A negative correlation among phytate and Fe availability was found when increased levels of amaranth.Ferritin concentration was found 2.7- and 2.0-fold higher (P<0.05) in cultures exposed to 20% and 40% of amaranth formulated bread samples, respectively, compared to control bread. The soluble phytate/Fe molar ratio explained the whole amaranth flour-mediated inhibitory effect associated to the limitation of available Fe; however, the use up to 20% of amaranth in bread formulation appears as a promising strategy to improve the nutritional value of bread, as indicated by the ferritin concentrations quantified in cell cultures. Higher proportion of amaranth flour increased Fe concentration although there was not detected any increase in Fe uptake.
Asunto(s)
Amaranthus/química , Pan/análisis , Harina/análisis , Hierro de la Dieta/farmacocinética , Ácido Fítico/farmacología , Absorción/efectos de los fármacos , Disponibilidad Biológica , Células CACO-2 , Diálisis , Suplementos Dietéticos , Ferritinas/análisis , Humanos , Fosfatos de Inositol/metabolismo , Hierro de la Dieta/análisis , Valor Nutritivo , TriticumRESUMEN
This study was conducted to evaluate the oral absorption of enrofloxacin (ENFX) in rats when administered with orange oil or its main component, limonene. Compared with the group administered ENFX alone, the ENFX + limonene group did not show any significant difference in the absorption of ENFX, whereas the extent and rate of absorption of ENFX were significantly decreased in the ENFX + orange oil group (C(max), -43%; T(max), 129%). In addition, t(1/2λz) and MRT of ENFX were prolonged by the concomitant administration of orange oil. The AUCs of ENFX were not affected in the ENFX + orange oil group. These results suggest that decreased oral absorption could reduce the efficacy of ENFX therapy in animals.
Asunto(s)
Antibacterianos/farmacocinética , Ciclohexenos/farmacocinética , Fluoroquinolonas/farmacocinética , Aceites de Plantas/farmacocinética , Terpenos/farmacocinética , Absorción/efectos de los fármacos , Administración Oral , Animales , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Ciclohexenos/administración & dosificación , Ciclohexenos/sangre , Combinación de Medicamentos , Interacciones Farmacológicas , Enrofloxacina , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/sangre , Limoneno , Masculino , Aceites de Plantas/administración & dosificación , Ratas , Ratas Sprague-Dawley , Terpenos/administración & dosificación , Terpenos/sangreRESUMEN
The methanol extract of Dypsis lutescens leaves showed inhibitory effects on lipase activity in vitro and on triglyceride accumulation in 3T3-L1 pre-adipocytes. Further experiments using the extract on mice demonstrated a suppressive effect on the postprandial elevation of blood triglyceride level and an anti-obesity effect on obese mice induced by a high-fat diet. D. lutescens will accordingly be useful for preventing obesity.
Asunto(s)
Arecaceae/química , Extractos Vegetales/farmacología , Hojas de la Planta/química , Triglicéridos/metabolismo , Células 3T3-L1 , Absorción/efectos de los fármacos , Adipocitos/citología , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Masculino , RatonesRESUMEN
ETHNOPHARMACOLOGY: The main components of HuangKui capsules' are the total flavonoids extracted from the flowers of Abelmoschus manihot L medic. They have been widely used to treat chronic glomerulonephritis, diabetic nephropathy and nephrotic syndrome. The combination of HuangKui capsules and glibenclamide is a possible therapy for patients with diabetes mellitus and diabetic nephropathy. However, there is no report about effects of HuangKui capsules on the glibenclamide pharmacokinetics till now. AIM OF THE STUDY: This study was aimed investigating the effect of HuangKui capsules on pharmacokinetics of glibenclamide in rats. MATERIAL AND METHODS: Eight rats were administered with an oral dose of HuangKui capsules (0.75gkg(-1)) once daily for 10 consecutive days. All the rats were administered orally with the glibenclamide (1mgkg(-1)) before the first time and after the last time given HuangKui capsules. LC-MS/MS was utilized to determine the concentration of glibenclamide in rat plasma and to calculate the corresponding pharmacokinetic parameters. The statistical differences of the two cycles were evaluated by paired-samples t-test. RESULTS: In the rats treated with HuangKui capsules and glibenclamide, the t(1/2), the time point of maximum plasma concentration (T(max)) of glibenclamide increased obviously (p<0.05) compared with the glibenclamide alone, while maximum plasma concentrations (C(max)), area under the plasma concentration-time curve (AUC((0-t))) decreased significantly (p<0.05). There was no significant difference between other parameters. CONCLUSION: HuangKui capsules can reduce the absorption of glibenclamide and accelerate the metabolism of glibenclamide.
Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Gliburida/farmacocinética , Interacciones de Hierba-Droga , Hipoglucemiantes/farmacocinética , Malvaceae , Absorción/efectos de los fármacos , Animales , Área Bajo la Curva , Cápsulas , Gliburida/sangre , Hipoglucemiantes/sangre , Masculino , Ratas , Ratas Sprague-DawleyRESUMEN
Biologically inspired experimental process in synthesising nanoparticles is of great interest in present scenario. Biosynthesis of nanoparticles is considered to be one of the best green techniques in synthesising metal nanoparticles. Here, an in situ green biogenic synthesis of gold nanoparticles using aqueous extracts of Terminalia chebula as reducing and stabilizing agent is reported. Gold nanoparticles were confirmed by surface plasmon resonance in the range of 535 nm using UV-visible spectrometry. TEM analysis revealed that the morphology of the particles thus formed contains anisotropic gold nanoparticles with size ranging from 6 to 60 nm. Hydrolysable tannins present in the extract of T. chebula are responsible for reductions and stabilization of gold nanoparticles. Antimicrobial activity of gold nanoparticles showed better activity towards gram positive S. aureus compared to gram negative E. coli using standard well diffusion method.
Asunto(s)
Oro/química , Tecnología Química Verde/métodos , Nanopartículas del Metal/química , Nanotecnología/métodos , Terminalia/química , Absorción/efectos de los fármacos , Antibacterianos/farmacología , Coloides , Escherichia coli/efectos de los fármacos , Nanopartículas del Metal/ultraestructura , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/química , Potenciometría , Soluciones , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de Fourier , Staphylococcus aureus/efectos de los fármacos , Difracción de Rayos XRESUMEN
Stem bromelain (SBM) is a therapeutic protein that has been studied for alkaline denaturation in the intestines, the principal site of its absorption. In this study, we investigated fluorinated alcohol 2,2,2-trifluoroethanol (TFE)-induced conformational changes in the specific/pre-molten globule (SMG) state of SBM observed at pH 10 by spectroscopic methods. Far-UV circular dichroism (CD) spectra showed that the protein retained its native-like secondary structure at TFE concentrations of up to 30% with a pronounced minimum at 222 nm, characteristic of a helix. However, addition of slightly higher TFE concentrations (≥40%) resulted in an â¼2.5-fold induction of this helical feature and a time-dependent increase in non-amyloidic turbidity as evidenced by turbidometric, Congo red-binding, and Thioflavin T (ThT)-binding studies. Near-UV CD spectra suggested a gradual but significant loss of tertiary structure at 10-30% TFE. Tryptophan studies showed blue-shifted fluorescence, although the number of accessible tryptophans remained the same up to 30% TFE. The SMG showed enhanced binding of the fluorescent probe 1-anilino-8-naphthalene sulfonic acid (ANS) up to 30% TFE, beyond which binding plateaued. Thermal and guanidine hydrochloride (GdnHCl) transition studies in the near-UV range indicated a single cooperative transition for the SMG state in the presence of 30% TFE, similar to that observed for native SBM at pH 7.0 (although with different T(m)s), unlike the SMG state. TFE (30%) appeared to induce native-like stability to the original SMG. These observations suggest a transformation of the SMG to a characteristic molten globule (MG) conformation at 30% TFE, possibly due to TFE-induced rearrangement of hydrophobic interactions at the protein's isoelectric point.
Asunto(s)
Amiloide/química , Bromelaínas/química , Bromelaínas/metabolismo , Trifluoroetanol/farmacología , Absorción/efectos de los fármacos , Acrilamida/química , Naftalenosulfonatos de Anilina/metabolismo , Dicroismo Circular , Estabilidad de Enzimas/efectos de los fármacos , Guanidina/farmacología , Punto Isoeléctrico , Nefelometría y Turbidimetría , Unión Proteica/efectos de los fármacos , Conformación Proteica/efectos de los fármacos , Desnaturalización Proteica/efectos de los fármacos , Espectrometría de Fluorescencia , Temperatura , Triptófano/metabolismoRESUMEN
The giant jellyfish Nemopilema nomurai (reaching sizes of up to 2 m diameter and 150 kg), which forms dense blooms, has caused extensive damage to fisheries by overloading trawl nets, while its toxic nematocysts cause dermatological symptoms. Giant jellyfish are currently discarded on the grounds of pest control. However, the giant jellyfish is considered to be edible and is part of Chinese cuisine. Therefore, we investigated whether any benefits for human health may be derived from consumption of the jellyfish in order to formulate medicated diets. Antioxidant activity of Nemopilema nomurai was measured using the oxygen radical absorbance capacity (ORAC) and hydroxyl radical averting capacity (HORAC) methods. Based on the results, the ORAC value of the giant jellyfish freeze-dried sample was 541 µmol trolox equivalent (TE)/100 g and the HORAC value was 3,687 µmol gallic acid equivalent (GAE)/100 g. On the other hand, the IC50 value of hydroxyl radical scavenging activity measured by using the electron spin resonance method was 3.3%. In conclusion, the results suggest that the freeze-dried powder of the giant jellyfish Nemopilema nomurai is a potentially beneficial food for humans.
Asunto(s)
Antioxidantes/farmacología , Radical Hidroxilo/metabolismo , Oxígeno/metabolismo , Escifozoos/química , Absorción/efectos de los fármacos , Animales , Depuradores de Radicales Libres/farmacología , Alimentos Funcionales , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Radical Hidroxilo/química , Concentración 50 InhibidoraRESUMEN
Pharmacological inhibition of dietary lipid absorption induces favorable changes in serum lipoprotein levels in patients that are at risk for cardiovascular disease and is considered an adjuvant or alternative treatment with HMG-CoA reductase inhibitors (statins). Here we demonstrate the feasibility of identifying novel inhibitors of intestinal lipid absorption using the zebrafish system. A pilot screen of an unbiased chemical library identified novel compounds that inhibited processing of fluorescent lipid analogues in live zebrafish larvae. Secondary assays identified those compounds suitable for testing in mammals and provided insight into mechanism of action, which for several compounds could be distinguished from ezetimibe, a drug used to inhibit cholesterol absorption in humans that broadly inhibited lipid absorption in zebrafish larvae. These findings support the utility of zebrafish screening assays to identify novel compounds that target complex physiological processes.